Fetuses’ that are growth restricted are at increased risk of stillbirth. Unfortunately, the clinical tools currently used to detect small babies perform modestly.
We are undertaking a large research program to discover new molecules in the mum’s blood that could flag babies that are growth restricted, and at risk of stillbirth. We hope to generate a new clinical test that can reduce rates of stillbirth across the globe.
Professor Stephen Tong is an academic OB/GYN based in Melbourne. He received his education at Monash University in Melbourne, Victoria, Australia. He is Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynecologists. He is currently Professor of Obstetrics and Gynaecology, University of Melbourne and Consultant Obstetrician, Mercy Hospital for Women in Heidelberg, Victoria, Australia.
Over the past decade he has led the translation of new treatment for ectopic pregnancy and preeclampsia, from laboratory concept to phase I-III clinical trials running across many countries (from South Africa, UK to New Zealand). He also leads a program of research that is hunting for a new blood test that may help women avoid a stillbirth.
Professor Tong has disclosed that she does not have any real or perceived conflicts of interest in making this presentation.
This presentation was part of the Stillbirth Summit 2021. This individual lecture will be awarded .75 hours of continuing education credit to include viewing the lecture and completing evaluation and post-test. Once received a certificate will be emailed to the address you provide in the post-test. If you did not register for the Summit WITH Continuing Education, you can purchase the continuing education by clicking here. This purchase will provide you access to all Stillbirth Summit 2021 lectures including continuing education credit. There is no charge for viewing the presentation.
Please feel free to ask questions of the presenter. We will obtain their answers/comments and provide them here as received.